Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.
Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, Sanila M, Parviainen J, Uksila J, Vainionpää R, Toivanen A. Yli-Kerttula T, et al. Among authors: mottonen t. Ann Rheum Dis. 2000 Jul;59(7):565-70. doi: 10.1136/ard.59.7.565. Ann Rheum Dis. 2000. PMID: 10873968 Free PMC article. Clinical Trial.
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study).
Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppänen O, Luosujärvi R, Luukkainen R, Karjalainen A, Blåfield H, Uutela T, Ilva K, Julkunen HA, Paimela L, Puolakka K, Moilanen E, Hannonen PJ, Möttönen T; NEO-RACo Study Group. Leirisalo-Repo M, et al. Among authors: mottonen t. Ann Rheum Dis. 2013 Jun;72(6):851-7. doi: 10.1136/annrheumdis-2012-201365. Epub 2012 Jun 30. Ann Rheum Dis. 2013. PMID: 22753402 Clinical Trial.
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial.
Rantalaiho V, Kautiainen H, Korpela M, Hannonen P, Kaipiainen-Seppänen O, Möttönen T, Kauppi M, Karjalainen A, Laiho K, Laasonen L, Hakola M, Peltomaa R, Leirisalo-Repo M; NEO-RACo Study Group. Rantalaiho V, et al. Among authors: mottonen t. Ann Rheum Dis. 2014 Nov;73(11):1954-61. doi: 10.1136/annrheumdis-2013-203497. Epub 2013 Aug 1. Ann Rheum Dis. 2014. PMID: 23908187 Clinical Trial.
Persistence of parvovirus B19 in synovial fluid and bone marrow.
Nikkari S, Roivainen A, Hannonen P, Möttönen T, Luukkainen R, Yli-Jama T, Toivanen P. Nikkari S, et al. Among authors: mottonen t. Ann Rheum Dis. 1995 Jul;54(7):597-600. doi: 10.1136/ard.54.7.597. Ann Rheum Dis. 1995. PMID: 7668905 Free PMC article.
Does parvovirus B19 have a role in rheumatoid arthritis?
Nikkari S, Luukkainen R, Möttönen T, Meurman O, Hannonen P, Skurnik M, Toivanen P. Nikkari S, et al. Among authors: mottonen t. Ann Rheum Dis. 1994 Feb;53(2):106-11. doi: 10.1136/ard.53.2.106. Ann Rheum Dis. 1994. PMID: 8129454 Free PMC article.
170 results